A nurse short message service by cellular phone in type-2 diabetic patients for six months

被引:105
|
作者
Kim, Hee-Seung
Jeong, Hye-Sun
机构
[1] Catholic Unic, Coll Nursing, Seoul 137701, South Korea
[2] KeuKdong Coll, Dept Nursing, Chungju, South Korea
关键词
education; glycosylated hemoglobin; Internet; nursing; short message service; type-2 diabetes mellitus;
D O I
10.1111/j.1365-2702.2007.01698.x
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Aim. To investigate the effectiveness of a nurse short message service (SMS) by cellular phone and wire Internet on plasma glucose levels in people with diabetes for six months. Background. Blood glucose management system using telemedicine approaches may maintain the appropriate blood glucose levels in type-2 diabetic patients. Design. A control group pre-test-post-test design was used to assess the effectiveness of nurse's education. Methods. Twenty-five patients were randomly assigned to an intervention group and 26 to a control group. The intervention was applied for six months. The goal of the intervention was to keep blood glucose concentrations close to the normal range. Participants were requested to input their blood glucose level, diet and exercise diary everyday in the website by cellular phone or wire Internet. The researcher sends optimal recommendations to each patient using SMS by cellular phone and wire Internet weekly. Results. Glycosylated hemoglobin (HbA(1)c) decreased 1.15% points at three months and 1.05% points at six months compared with baseline in the intervention group. Patients in the intervention group had a decrease of two hours post meal glucose (2HPMG) of 85.1 mg/dl at three months and 63.1 mg/dl at six months compared with baseline. Conclusion. This web-based intervention using SMS of cellular phone improved HbA(1)c and 2HPMG for six months in type-2 diabetic patients. Relevance to clinical practice. An SMS of cellular phone intervention by a nurse can reduce HbA(1)c and 2HPMG for six months in type-2 diabetic patients.
引用
收藏
页码:1082 / 1087
页数:6
相关论文
共 50 条
  • [21] PRESCRIBING PATTERN OF ANTIDIABETIC DRUGS IN TYPE-2 DIABETIC PATIENTS
    Venkateswaramurthy, N.
    Mohammed, Shajeem S.
    Sambathkumar, R.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2016, 7 (11): : 4550 - 4555
  • [22] FLUOXETINE IN THE TREATMENT OF OBESE TYPE-2 DIABETIC-PATIENTS
    OKANE, M
    WILES, PG
    WALES, JK
    [J]. DIABETIC MEDICINE, 1994, 11 (01) : 105 - 110
  • [23] CATABOLISM OF HDL LIPOPROTEINS IN TYPE-2 DIABETIC-PATIENTS
    GOLAY, A
    CHEN, YDI
    REAVEN, GM
    [J]. DIABETES & METABOLISM, 1986, 12 (02): : 99 - 99
  • [24] CHOLESTERYL ESTER TRANSFER IN TYPE-2 DIABETIC-PATIENTS
    MURAKAMI, T
    MIZUSHIMA, Y
    GIANFRANCESCHI, G
    SIRTORI, CR
    FRANCESCHINI, G
    [J]. DIABETOLOGIA, 1995, 38 : A249 - A249
  • [25] Evaluation of periodontal surgical procedures in type-2 diabetic patients
    Oswal, Sheetal K.
    Dwarkanath, C. D.
    Ramesh, A. V.
    [J]. INTERNATIONAL JOURNAL OF STOMATOLOGY & OCCLUSION MEDICINE, 2011, 4 (02) : 59 - 66
  • [26] PREDICTORS OF THE DEVELOPMENT OF MICROALBUMINURIA IN TYPE-2 DIABETIC-PATIENTS
    MATTOCK, M
    BARNES, D
    VIBERTI, GC
    KEEN, H
    FITZGERALD, A
    BURT, D
    JACKSON, PG
    [J]. DIABETOLOGIA, 1995, 38 : A63 - A63
  • [27] Frequency of attendance and degree of control of type-2 diabetic patients
    Ortiz Tobarra, Maria Trinidad
    Orozco Beltran, Domingo
    Gil Guillen, Vicente
    Terol Molto, Cecilia
    [J]. ATENCION PRIMARIA, 2008, 40 (03): : 139 - 144
  • [28] HEMOSTATIC MEASURES IN TYPE-2 DIABETIC-PATIENTS WITH MICROALBUMINURIA
    SCHMITZ, A
    INGERSLEV, J
    [J]. DIABETIC MEDICINE, 1990, 7 (06) : 521 - 525
  • [29] A COMPARISON BETWEEN MOROCCAN AND BELGIAN TYPE-2 DIABETIC PATIENTS
    Riffi, A.
    Devroey, D.
    Van De Vijver, E.
    [J]. ACTA CLINICA BELGICA, 2012, 67 (04) : 246 - 249
  • [30] Mobile phone text messaging and Telephone follow-up in type 2 diabetic patients for 3 months: A comparative study
    Zolfaghari M.
    Mousavifar S.A.
    Haghani H.
    [J]. Journal of Diabetes & Metabolic Disorders, 11 (1):